MXPA03010811A - Compuestos heterociclico y uso farmaceutico. - Google Patents
Compuestos heterociclico y uso farmaceutico.Info
- Publication number
- MXPA03010811A MXPA03010811A MXPA03010811A MXPA03010811A MXPA03010811A MX PA03010811 A MXPA03010811 A MX PA03010811A MX PA03010811 A MXPA03010811 A MX PA03010811A MX PA03010811 A MXPA03010811 A MX PA03010811A MX PA03010811 A MXPA03010811 A MX PA03010811A
- Authority
- MX
- Mexico
- Prior art keywords
- agent
- alkyl
- remedy
- same meaning
- heterocyclic compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El nuevo compuesto heterociclico de la presente invencion es un nuevo compuesto heterociclico que tiene la formula (I) (ver formula) donde R1 es H o alquilo C1-6, R7 es H, -CO-C(R4)=C(R4)-R5, donde R4 es H o alquilo C1-4, y R5 es alquilo C4-8, alquenilo C2-8 y similares, y otros, y es el siguiente grupo, donde X es O u S, R7, es el mismo que R4, R8 es R10-C(R9)=C(R9)-, donde R9 es el mismo que R4, R10 es C1-6 alquilo y similares, y otros, R14 es el mismo que R4 y R15 es arilo y similares, Y-(CH7)n-O- esta enlazado a la posicion 6 o 7 del esqueleto de la tetrahidroisoquinolina, y n es un numero entero de 1 a 4, o una sal farmaceuticamente aceptable del mismo. El compuesto (I) de la presente invencion es util como agente hipoglucemico, agente hipolipidemico, mejorador de la resistencia a la insulina, agente terapeutico de la diabetes, agente terapeutico de complicaciones diabeticas, mejorador de la tolerancia a la glucosa, agente antiarterioesclerosis, agente antiobesidad, agente antiinflamatorio, agente para la profilaxis o tratamiento de enfermedades mediadas por PPAR o agente para la profilaxis o el tratamiento del sindrome X.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001161489 | 2001-05-29 | ||
| PCT/JP2002/005097 WO2002096880A1 (fr) | 2001-05-29 | 2002-05-27 | Nouveau compose heterocyclique et son utilisation medicinale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010811A true MXPA03010811A (es) | 2004-02-27 |
Family
ID=19004756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010811A MXPA03010811A (es) | 2001-05-29 | 2002-05-27 | Compuestos heterociclico y uso farmaceutico. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7557123B2 (es) |
| EP (1) | EP1403253A4 (es) |
| JP (1) | JP4279136B2 (es) |
| KR (2) | KR100898358B1 (es) |
| CN (1) | CN1242994C (es) |
| AR (1) | AR036036A1 (es) |
| AU (1) | AU2002308889B2 (es) |
| BR (1) | BR0209711A (es) |
| CA (1) | CA2448634A1 (es) |
| CO (1) | CO5540342A2 (es) |
| CZ (1) | CZ20033450A3 (es) |
| HK (1) | HK1069385A1 (es) |
| HU (1) | HUP0401862A3 (es) |
| IL (1) | IL159085A0 (es) |
| MX (1) | MXPA03010811A (es) |
| NO (1) | NO326688B1 (es) |
| NZ (1) | NZ530358A (es) |
| PL (1) | PL367639A1 (es) |
| RU (1) | RU2299197C2 (es) |
| TW (1) | TWI297008B (es) |
| WO (1) | WO2002096880A1 (es) |
| YU (1) | YU94003A (es) |
| ZA (1) | ZA200309757B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002308891B2 (en) | 2001-05-29 | 2007-09-06 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic derivatives and medicinal use thereof |
| US7816385B2 (en) * | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
| JPWO2004106542A1 (ja) * | 2003-05-29 | 2006-07-20 | 三共株式会社 | インスリン抵抗性改善剤及びそのスクリーニング方法 |
| TWI359810B (en) | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
| US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
| WO2007058504A1 (en) * | 2005-11-21 | 2007-05-24 | Lg Life Sciences, Ltd. | Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| WO2012033195A1 (ja) * | 2010-09-10 | 2012-03-15 | 京都薬品工業株式会社 | 複素環化合物 |
| CN102807526B (zh) * | 2011-06-21 | 2015-12-02 | 寿光富康制药有限公司 | 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用 |
| WO2020013116A1 (ja) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Ｐｔｐ－１ｂ阻害剤およびその用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
| US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| CA2259431A1 (en) | 1996-07-01 | 1998-01-08 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
| EP0925063A4 (en) | 1996-07-01 | 2000-12-27 | Lilly Co Eli | Blood-glucose-lowering and lipid-lowering compounds |
| GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| CN1215059C (zh) | 1999-12-03 | 2005-08-17 | 京都药品工业株式会社 | 新的杂环化合物及其盐和它们的医药用途 |
| US20020037897A1 (en) | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| AU2002308891B2 (en) | 2001-05-29 | 2007-09-06 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic derivatives and medicinal use thereof |
-
2002
- 2002-05-27 MX MXPA03010811A patent/MXPA03010811A/es active IP Right Grant
- 2002-05-27 HU HU0401862A patent/HUP0401862A3/hu unknown
- 2002-05-27 RU RU2003137574/04A patent/RU2299197C2/ru not_active IP Right Cessation
- 2002-05-27 PL PL02367639A patent/PL367639A1/xx unknown
- 2002-05-27 CN CNB028109643A patent/CN1242994C/zh not_active Expired - Fee Related
- 2002-05-27 CA CA002448634A patent/CA2448634A1/en not_active Abandoned
- 2002-05-27 ZA ZA200309757A patent/ZA200309757B/en unknown
- 2002-05-27 US US10/478,862 patent/US7557123B2/en not_active Expired - Fee Related
- 2002-05-27 KR KR1020087023698A patent/KR100898358B1/ko not_active IP Right Cessation
- 2002-05-27 JP JP2003500060A patent/JP4279136B2/ja not_active Expired - Fee Related
- 2002-05-27 CZ CZ20033450A patent/CZ20033450A3/cs unknown
- 2002-05-27 IL IL15908502A patent/IL159085A0/xx unknown
- 2002-05-27 KR KR10-2003-7015611A patent/KR20040030647A/ko not_active IP Right Cessation
- 2002-05-27 BR BR0209711-7A patent/BR0209711A/pt not_active IP Right Cessation
- 2002-05-27 EP EP02774070A patent/EP1403253A4/en not_active Withdrawn
- 2002-05-27 AU AU2002308889A patent/AU2002308889B2/en not_active Ceased
- 2002-05-27 NZ NZ530358A patent/NZ530358A/en unknown
- 2002-05-27 WO PCT/JP2002/005097 patent/WO2002096880A1/ja active Application Filing
- 2002-05-27 YU YU94003A patent/YU94003A/sh unknown
- 2002-05-28 TW TW091111315A patent/TWI297008B/zh active
- 2002-05-29 AR ARP020102002A patent/AR036036A1/es unknown
-
2003
- 2003-11-28 NO NO20035331A patent/NO326688B1/no not_active IP Right Cessation
- 2003-12-29 CO CO03112806A patent/CO5540342A2/es not_active Application Discontinuation
-
2005
- 2005-03-02 HK HK05101815A patent/HK1069385A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040030647A (ko) | 2004-04-09 |
| TWI297008B (en) | 2008-05-21 |
| JP4279136B2 (ja) | 2009-06-17 |
| NZ530358A (en) | 2005-04-29 |
| IL159085A0 (en) | 2004-05-12 |
| AU2002308889B2 (en) | 2007-09-06 |
| EP1403253A1 (en) | 2004-03-31 |
| KR100898358B1 (ko) | 2009-05-20 |
| CN1527819A (zh) | 2004-09-08 |
| BR0209711A (pt) | 2004-11-03 |
| HK1069385A1 (en) | 2005-05-20 |
| NO326688B1 (no) | 2009-01-26 |
| HUP0401862A3 (en) | 2009-03-30 |
| US7557123B2 (en) | 2009-07-07 |
| NO20035331D0 (no) | 2003-11-28 |
| CO5540342A2 (es) | 2005-07-29 |
| CN1242994C (zh) | 2006-02-22 |
| EP1403253A4 (en) | 2005-03-30 |
| KR20080093076A (ko) | 2008-10-17 |
| RU2299197C2 (ru) | 2007-05-20 |
| US20040220215A1 (en) | 2004-11-04 |
| CA2448634A1 (en) | 2002-12-05 |
| PL367639A1 (en) | 2005-03-07 |
| AR036036A1 (es) | 2004-08-04 |
| RU2003137574A (ru) | 2005-05-20 |
| YU94003A (sh) | 2006-08-17 |
| JPWO2002096880A1 (ja) | 2004-09-09 |
| ZA200309757B (en) | 2004-12-22 |
| CZ20033450A3 (cs) | 2004-05-12 |
| WO2002096880A1 (fr) | 2002-12-05 |
| HUP0401862A2 (hu) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60139025D1 (de) | Alkansäurederivate, verfahren zu deren herstellung und deren verwendung | |
| NZ508066A (en) | Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity | |
| CA2316902A1 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
| IE44246L (en) | Heterocyclyloxypropanolamines | |
| MXPA05008600A (es) | Compuestos para el tratamiento de desordenes metabolicos. | |
| CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
| HK1083460A1 (en) | Compounds for the treatment of metabolic disorders | |
| HK1083462A1 (en) | Compounds for the treatment of metabolic disorders | |
| YU50302A (sh) | Nova heterociklična jedinjenja, njihove soli i njihova primena u medicini | |
| MXPA03010811A (es) | Compuestos heterociclico y uso farmaceutico. | |
| MY140325A (en) | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| MXPA03010867A (es) | Nuevos derivados heterociclicos y uso farmaceutico de los mismos. | |
| KR900016098A (ko) | 카페인산의 유도체 및 이를 함유하는 약제학적 조성물 | |
| NZ501785A (en) | 4-(3,4-dihydro-2-naphthylmethyl)- or 4-(2H-3-chromenylmethyl)-4,5-dihydro-1H-imidazole derivatives | |
| EP1156057A4 (en) | MALTO-OLIGOSACCHARID DERIVATIVES AND THEIR APPLICATIONS | |
| NZ511572A (en) | Eudesmadienolide derivatives useful as glucose and lipid lowering compounds | |
| AU4301189A (en) | New thienyloxy-alkylamine derivates, their process of production and medicaments containing these compounds | |
| FI892685A0 (fi) | Menetelmä uusien, sytostaattisesti vaikuttavien antrasykliinijohdannaisten valmistamiseksi | |
| AU2224795A (en) | Ameliorant or remedy for paraneoplastic syndrome | |
| ES2007784A6 (es) | Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea> | |
| BRPI0411136A (pt) | composto carboxìlico e medicamento consistindo no mesmo | |
| IE782313L (en) | Naphthalene derivatives | |
| DK0504807T3 (da) | Anvendelse af bis(p-hydroxyphenylthio)methanderivater til inhibering af progressiv udvikling af insulinafhængig diabetes mellitus | |
| IE780559L (en) | Furoyl- and thenoyl-aryloxyalkyl carboxylic acid | |
| KR940021526A (ko) | 카르복실산 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |